# FDA recall D-0832-2020

> **Graviti Pharmaceuticals Private Limited** · Class II · drug recall initiated 2020-01-28.

## Product

Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11.

## Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0832-2020
- **Recalling firm:** Graviti Pharmaceuticals Private Limited
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-01-28
- **Report date:** 2020-02-12
- **Termination date:** 2022-11-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Medak, N/A, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0832-2020

## Citation

> AI Analytics. FDA recall D-0832-2020. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0832-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*